IOVA icon

Iovance Biotherapeutics

294 hedge funds and large institutions have $1.86B invested in Iovance Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 114 increasing their positions, 80 reducing their positions, and 41 closing their positions.

Holders
294
Holders Change
+22
Holders Change %
+8.09%
% of All Funds
4.28%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.07%
New
67
Increased
114
Reduced
80
Closed
41
Calls
$25.3M
Puts
$18.5M
Net Calls
+$6.75M
Net Calls Change
-$55.7M
Name Market Value Shares Shares
Change
Shares
Change %
HFM
326
Harvest Fund Management
China
-4,208 Closed
LFG
327
Larson Financial Group
Missouri
-1,000 Closed
First Manhattan
328
First Manhattan
New York
-550 Closed
FIM
329
Fernwood Investment Management
Massachusetts
-400 Closed
OPTFSNA
330
Old Point Trust & Financial Services N A
Virginia
-250 Closed
MAM
331
Meeder Asset Management
Ohio
-88 Closed
SIS
332
Sound Income Strategies
Florida
-50 Closed
AWM
333
Avior Wealth Management
Nebraska
-46 Closed
CIBC Private Wealth Group
334
CIBC Private Wealth Group
Georgia
-35 Closed
TC
335
Torno Capital
Massachusetts
CSS
336
Cubist Systematic Strategies
Connecticut
BFM
337
Boothbay Fund Management
New York
Belvedere Trading
338
Belvedere Trading
Illinois
PI
339
PEAK6 Investments
Illinois
Walleye Trading
340
Walleye Trading
New York
Parallax Volatility Advisers
341
Parallax Volatility Advisers
California
WVP
342
Worth Venture Partners
New Jersey
JGC
343
J. Goldman & Co
New York
CFGS
344
Concourse Financial Group Securities
Alabama
UOC
345
UBS O'Connor
Illinois
CF
346
Cantor Fitzgerald
New York
C
347
Covestor
United Kingdom
$0 16 +6 +60%